Skip to content

Do not forget the lungs: I/E mode physiotherapy for people recovering from COVID-19. Preliminary feasibility study

Do not forget the lungs: I/E mode physiotherapy for people recovering from COVID-19. Preliminary feasibility study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048830
Enrollment
Unknown
Registered
2021-07-18
Start date
2020-08-01
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post covid 19 syndrome

Interventions

post covid 19:T-PEP 4

Sponsors

asl4 chiavarese chiavari
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years 2. Discharged from hospital after a COVID19 pneumonia 3. In spontaneous breathing 4. Able to breathe keeping a mouthpiece 5. Mild to moderate obstructive syndrome at spirometry (12) and at least one symptom among: (1) Breathlessness or feeling as I can't take a deep breath or inability to yawn (2) Cough (3) Chest pain/Chest tightness (4) Dyspnoea (at rest or during normal ADL) (5) Oxygen desaturation >=4% during daily physical activities

Exclusion criteria

Exclusion criteria: - Already on treatment with NIV or CPAP before COVID 19 - Oxygen supplementation at rest - Inability or refusal to collaborate - Lack of informed consent - Severe obstructive syndrome ( forced expiratory volume 1 second - FEV1 - < 50% )

Design outcomes

Primary

MeasureTime frame
The primary outcomes were changes in symptoms scores and CAT.;

Secondary

MeasureTime frame
Secondary outcomes were changes in respiratory function parameters, exercise capacity, respiratory muscles strength (MIP, MEP and SNIP ) and cough efficacy (PCEF);

Countries

Italy

Contacts

Public ContactBruna GRECCHI
bruna.grecchi14@gmail.com00393498448047

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026